Uncategorized

ImPact Biotech Announces Research Collaboration to develop a treatment to arrest Pathologic Myopia using its Padeliporfin minimally invasive platform

ImPact Biotech recently announced an agreement with Maastricht University to collaborate in research focused on eye treatment to arrest the progression of the severe eye disease Pathological Myopia, also known as Myopic Macular Degeneration.

ImPact Biotech Announces Research Collaboration to develop a treatment to arrest Pathologic Myopia using its Padeliporfin minimally invasive platform Read More »

Bio-Thera Solutions Announces Positive Phase 1 Clinical Data for BAT8006 (Folate-Receptor-α-ADC) and Presents Phase 1 Dose Escalation Study at the Bethune Obstetrics and Gynecology Forum

Bio-Thera Solutions, Ltd announced positive Phase 1 clinical data for BAT8006 as part of a presentation of the clinical results of a Phase 1 dose escalation study evaluating the safety and efficacy of BAT8006 at the Bethune Obstetrics and Gynecology Forum in China.

Bio-Thera Solutions Announces Positive Phase 1 Clinical Data for BAT8006 (Folate-Receptor-α-ADC) and Presents Phase 1 Dose Escalation Study at the Bethune Obstetrics and Gynecology Forum Read More »

Entrevista a Timothy Dhalleine, fotógrafo y director | “Esperamos dar voz a la enfermedad de Huntington más allá del mundo médico”

El realizador audiovisual estrenará el cortometraje “The Present” sobre Dimitri Poffé, quien, tras un test genético, se dedicó a viajar y crear conciencia sobre esta patología. Para Dhalleine, “el arte es la mejor manera de conectar al público con lo que importa”.

Entrevista a Timothy Dhalleine, fotógrafo y director | “Esperamos dar voz a la enfermedad de Huntington más allá del mundo médico” Read More »

Scroll to Top